NOC2L
Basic information
Region (hg38): 1:944203-959309
Links
Phenotypes
GenCC
Source: 
ClinVar
This is a list of variants' phenotypes submitted to 
- not_specified (147 variants)
- not_provided (12 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NOC2L gene is commonly pathogenic or not. These statistics are base on transcript: NM_000015658.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum | 
|---|---|---|---|---|---|---|
| synonymous | 11 | |||||
| missense | 136 | 11 | 147 | |||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 136 | 17 | 5 | 
GnomAD
Source: 
| Gene | Type | Bio Type | Transcript | Coding Exons | Length | 
|---|---|---|---|---|---|
| NOC2L | protein_coding | protein_coding | ENST00000327044 | 19 | 15106 | 
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p | 
|---|---|---|---|---|---|---|
| 2.89e-29 | 0.0000528 | 125546 | 0 | 201 | 125747 | 0.000800 | 
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -1.90 | 577 | 462 | 1.25 | 0.0000293 | 4856 | 
| Missense in Polyphen | 140 | 135.62 | 1.0323 | 1490 | ||
| Synonymous | -6.71 | 320 | 199 | 1.60 | 0.0000137 | 1471 | 
| Loss of Function | -0.174 | 43 | 41.8 | 1.03 | 0.00000215 | 447 | 
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p | 
|---|---|---|
| African & African-American | 0.00112 | 0.00111 | 
| Ashkenazi Jewish | 0.00428 | 0.00428 | 
| East Asian | 0.000931 | 0.000925 | 
| Finnish | 0.0000462 | 0.0000462 | 
| European (Non-Finnish) | 0.000830 | 0.000800 | 
| Middle Eastern | 0.000931 | 0.000925 | 
| South Asian | 0.000500 | 0.000490 | 
| Other | 0.00133 | 0.00130 | 
dbNSFP
Source: 
- Function
- FUNCTION: Acts as an inhibitor of histone acetyltransferase activity; prevents acetylation of all core histones by the EP300/p300 histone acetyltransferase at p53/TP53-regulated target promoters in a histone deacetylases (HDAC)-independent manner. Acts as a transcription corepressor of p53/TP53- and TP63-mediated transactivation of the p21/CDKN1A promoter. Involved in the regulation of p53/TP53-dependent apoptosis. Associates together with TP63 isoform TA*-gamma to the p21/CDKN1A promoter. {ECO:0000269|PubMed:16322561, ECO:0000269|PubMed:20123734, ECO:0000269|PubMed:20959462}.;
- Pathway
- Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;Validated transcriptional targets of TAp63 isoforms;Regulation of TP53 Activity through Phosphorylation;Regulation of TP53 Activity;Transcriptional Regulation by TP53 (Consensus) 
Recessive Scores
- pRec
- 0.139
Intolerance Scores
- loftool
- 0.887
- rvis_EVS
- 0.04
- rvis_percentile_EVS
- 56.27
Haploinsufficiency Scores
- pHI
- 0.240
- hipred
- Y
- hipred_score
- 0.519
- ghis
- 0.526
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.946
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium | 
| Primary Immunodeficiency | Medium | Medium | Medium | 
| Cancer | Medium | Medium | Medium | 
Mouse Genome Informatics
- Gene name
- Noc2l
- Phenotype
- endocrine/exocrine gland phenotype; cellular phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; immune system phenotype;
Zebrafish Information Network
- Gene name
- noc2l
- Affected structure
- anatomical system
- Phenotype tag
- abnormal
- Phenotype quality
- quality
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;negative regulation of B cell apoptotic process;apoptotic process;chromatin assembly;cellular response to UV;negative regulation of histone acetylation;ribosomal large subunit biogenesis;regulation of signal transduction by p53 class mediator;negative regulation of intrinsic apoptotic signaling pathway
- Cellular component
- nucleus;nucleoplasm;nucleolus;cytosol;Noc1p-Noc2p complex;Noc2p-Noc3p complex
- Molecular function
- chromatin binding;transcription corepressor activity;RNA binding;protein binding;nucleosome binding;histone binding;repressing transcription factor binding